
51 - 200 employees
🏥 Healthcare
🧬 Biotechnology
💊 Pharmaceuticals
💰 $96.9M Post-IPO Equity - Rezolute on 2025-04
Healthcare • Biotechnology • Pharmaceuticals
Rezolute, Inc. is a biopharmaceutical company focused on developing and delivering novel therapies for rare metabolic disorders, specifically hyperinsulinism. The company’s lead program, ersodetug, has two Phase 3 programs targeting congenital and tumor hyperinsulinism, and Rezolute conducts clinical trials, investigator-initiated studies, and publishes clinical outcomes. Rezolute also engages with patients, investors, and the medical community to improve care and quality of life for affected patients and families.
📡 We watch Rezolute, Inc.'s careers page
Every 2 hours
how often we check
5
roles posted in the last 30 days
About 22 days
usual time to fill a role
6
roles closed in the last year
Selected: 🇺🇸 United States – Remote USA.
Selected: 🆕 Date Added.
🔥 4 hours ago
Vice President leading Rezolute’s outsourced global biologics manufacturing network for rare-disease therapies. Overseeing ersodetug production from cell line through commercial supply.
🇺🇸 United States – Remote
💵 $290k - $340k / year
💰 $96.9M Post-IPO Equity - Rezolute on 2025-04
⏰ Full Time
🔴 Lead
👔 Vice President
👻 Ghost score 0%
🕒 October 2
Pharmacovigilance leader building inspection-ready drug-safety operations for Rezolute’s rare-disease biopharmaceutical therapies. Leading launch readiness, safety surveillance, vendors, compliance, and regulatory submissions.
🇺🇸 United States – Remote
💵 $255k - $315k / year
💰 $96.9M Post-IPO Equity - Rezolute on 2025-04
⏰ Full Time
🟠 Senior
⚙️ Operations
👻 Ghost score 3%